Malignant fibrous histiocytoma was diagnosed in seven cats from biopsy specimens received at the University of Missouri Veterinary Medical Diagnostic Laboratory during a 4-year period from 1987-1 99 1. Tissue blocks from formalin-fixed specimens were resectioned and stained for type I (AE1) and type I1 (AE3) cytokeratins, desmin, S 100 protein, vimentin. and alpha, -antitrypsin by the avidin biotin peroxidase complex method with diaminobenzidine (DAB) chromogen. None of the tumors stained positively for alpha, -antitrypsin. Four of seven of the tumors had similar immunohistochemical staining results, with positive staining for type I and type I1 cytokeratins, desmin, SlOO protein, and vimentin. Of the remaining three, one stained positively only for SlOO protein and vimentin: one stained positively for vimentin only; and one was negative for all six antigens. Based only on immunohistochemical staining results, three oithe tumors could possibly be reclassified: one as a melanoma, one as a probable fibrosarcoma, and one as unknown. These results also indicate that feline malignant fibrous histiocytomas show a diversity of intermediate filament expression, as do human tumors. Our results also do not support the theory that malignant fibrous histiocytomas are of histiocytic origin.
Malignant fibrous histiocytoma (MFH) is a soft tissue neoplasm of human beings and animals in which the cells have morphologic features of both fibroblasts and hiStioCYteS.7.16.~l. [31] [32] [33] In human beings, MFH is considered to be the most common soft tissue tumor of late adult life.3' Tumors in cats '.5.12-13.18-23 and dogsI3 with morphologic features similar to those of human MFH have been reported less frequently in the veterinary literature. Based on the morphologic features reported in other studies, extraskeletal giant cell tumor or giant cell tumors of soft parts in h o r s e~~O . '~-'~ and cats1.10.19 are probably the same tumor type.
The cell of origin of these tumor cells in uncertain, but several theories have been postulated. In one rep01-t'~ three possible cells of origin were proposed: 1) histiocytic cells able to function as "facultative fibroblasts,"*O 2) fibroblast^,^^ and 3 ) primitive mesenchymal cells able to differentiate into fibroblasts and histiocytes." Immunohistochemical studies have, in most cases, not supported the theory that these tumor cells are derived from true h i~t i o c y t e s . * .~"~~ Others have suggested that the immunohistologic heterogeneity of MFH tumor cells may indicate that these tumors are indeed from a primitive cell type or may be the end result of "dedifferentiation" of several different types of
This study was conducted to try to characterize im-munohistochemically the staining patterns of feline tumors diagnosed by morphologic appearance as MFH.
Materials and Methods
The tumors used in this study were obtained from routine biopsy specimens submitted to the University of Missouri Veterinary Medical Diagnostic Laboratory during a 4-year period from April 1987 through March 1991. Any feline neoplasms diagnosed as fibrous histiocytoma by morphologic criteria based on examination of hematoxylin and eosin-stained tissue sections were included in the study. Seven tumors were selected and are numbered 1 to 7. The seven tumors in the study were all from mixed breed cats. Six of seven of the cats were female; one was a castrated male. Of the six female cats, three were neutered. The cats ranged in age from 7 years to 14 years. All tissues were fixed in 10% neutral buffered formalin, embedded in paraffin blocks, and sectioned at 4 pm.
The following procedure was used for immunohistochemical staining of the seven cases (case Nos. 1-7). Four-micron paraffin sections were dewaxed in two changes of xylene for 10 minutes each and hydrated through graded alcohols. Sections stained with AE1 cytokeratin, AE3 cytokeratin, and alpha,-antitrypsin were treated with 0.1% trypsin and calcium chloride in Tris-buffered saline (TBS), pH 7.8, at 37 C for 60 minutes. All sections were treated with 3% hydrogen peroxide in methanol for 10 minutes at room temperature followed by several washes with TBS. Nonspecific antibody binding was blocked by 10-minute incubation at room tem- 
5 Antitrypsin = alpha,-antitrypsin. 11 0 indicates no staining. + indicates degree of positive staining: + = staining of scattered cells; + + = widespread staining of few cells or focal areas of heavy staining; + + + = widespread staining of many cells; + + + + = staining of essentially all cells through the tumor.
perature (25 C) with 10% normal serum from the species in which the secondary antibody was derived. Primary antibodies were diluted in TBS at the following dilutions: vimentin 1 : 40, desmin 1 : 20, alpha,-antitrypsin 1 : 800, AE1 (cytokeratin) 1 : 100, AE3 (cytokeratin) 1 : 200, SlOO 1 : 1600 (Dako, Carpinteria, CA). Primary antibody incubation and all subsequent steps were performed at room temperature for 30 minutes. A commercially available avidin biotin peroxidase complex method kit (Vector Laboratories, Burlingame, CA) was used for secondary antibodies and AB complex reagents. Diaminobenzidine (DAB substrate; Sigma Chemical, St. Louis, MO) was used as substrate. Substrate development was also performed at room temperature for 7 minutes. Slides were counterstained with Mayer's hematoxylin.
Reagents for vimentin, desmin, AE1, and AE3 were monoclonal. An inappropriate mouse antibody (antibody to cytomegalovirus) was used as a negative control for the monoclonals. Alpha, -antitrypsin and S 100 protein reagents were polyclonal. Normal horse serum was used as negative serum for the polyclonals.
Normal feline skin was used as an appropriate internal control for all antibodies except for alpha,-antitrypsin. Feline inflammatory skin lesions and normal feline liver were used as controls for alpha,-antitrypsin. AE1 stains sweat gland and outer root sheath epithelium and very lightly stains the epidermis. AE3 stains most epithelial structures, excluding germinal epithelium of hair follicles and sweat gland epithelium. Vimentin stains melanocytes, fibroblasts, endothelium, dermal papillae of hair follicles, plasma cells, and some smooth muscle. Desmin stains smooth and striated muscle exclusively. SlOO protein stains cutaneous nerves and most sebaceous glands. Alpha,-antitrypsin stains > 90% of macrophages and giant cells in inflammatory skin lesions and near 100% of Kupffer cells in normal feline liver.
Results
The seven tumors used in this study were diagnosed by light microscopic examination on morphologic criteria. These tumors had sheets of polygonal to spindloid cells with round, oval, or indented nuclei, variable amounts of eosinophilic cytoplasm, zero to two nucleoli, and distinct to indistinct cell outlines (Fig. 1) . These cells were often arranged in a storiform pattern. Multinucleated giant cells were present in variable numbers. Mitotic figures ranged from zero to two per 400x field.
Results of immunohistochemical staining for each tumor are summarized in Table 1 . Four of seven tumors (case Nos. 2, 5-7) stained positively for type I cytokeratin (Fig. 2) , type I1 cytokeratin ( Fig. 3 ) and desmin (Fig. 4) . Five of seven (case Nos. 2, 3, 5-7) were positive for S 100 protein (Fig. 5 ) and six of seven (case Nos. 2-7) were positive for vimentin ( Fig. 6 ). All seven of the tumors were negative for alpha, -antitrypsin. 
Discussion
The cell of origin of malignant fibrous histiocytomas (MFH) is not known. In previous reports this tumor was thought to arise from histiocytes. This was based primarily on tissue culture studies in which the cultured tumor cells had morphologic features of histiocytes and displayed ameboid movement and phago-cyto~is.',~~ The use of immunohistochemistry has provided researchers new techniques to study specific cell types through the use of antibodies to cell proteins specific for those cell types. Using a variety of these cell markers, immunohistochemical staining patterns of human malignant fibrous histiocytomas have been Positive immunohistochemical staining for neural markers, vimentin, desmin, and cytokeratins has been demonstrated. ' 5-17 Even though some recent studies still demonstrate positive staining Vet Pathol 31:2, 1994 Fig. 1.   Fig. 2.   Fig. 3.   Fig. 4.   Fig. 5.   Fig. 6 for histiocytic or macrophage markers on tumor myoid cells, or undifferentiated mesenchymal most of the current reports argue against the theory ~e l l s .~.~. ' 124-26.33 Markers previously used to identify histhat MFH are derived from histiocytes and suggest that tiocyte/macrophage origin such as alpha, -antitrypsin, the cell of origin is more closely related to fibroblasts, alpha,-chymotrypsin, and lysozyme have been shown to be nonspecific and proven not to be reliable markers for histiocytes or m a c r~p h a g e s .~.~~~~~ In addition to the immunohistochemical studies showing the heterogeneous nature of MFH, xenograft studies have shown that transplanted human tumors differentiate into various cell lineages in mice.*' At the present time, the most convincing evidence indicates that human MFH arise from primitive cells with a heterogeneous nature capable of differentiation into several cell lineages or that MFH represent the final stage of dedifferentiation of several different types of sarcoma^.^.'^.^^.^^
In one report of intermediate filament staining of canine skin and soft tissue tumors, one case of malignant fibrous histiocytoma was positive for monoclonal vimentin and was negative for polyclonal vimentin, polyclonal keratin, and polyclonal desmin using formalin-fixed t i~s u e .~
The same tumor was positive for both monoclonal vimentin and polyclonal desmin but was negative for polyclonal vimentin and polyclonal keratin on cytologic ~pecimens.~ Our results using type I cytokeratin, type I1 cytokeratin, desmin, S 100 protein, vimentin, and alpha,antitrypsin on seven feline tumors indicate that 1) immunohistochemical staining does not indicate a definitive cell of origin of feline fibrous histiocytomas, and 2) feline fibrous histiocytomas show a heterogeneous staining pattern similar to those seen in human malignant fibrous histiocytomas. Based on immunohistochemical staining results for type I cytokeratin, type I1 cytokeratin, desmin, S 100 protein, vimentin, and alpha,-antitrypsin, one ofthe seven tumors studied may be a melanoma (positive for SlOO and vimentin only), one may be a fibrosarcoma (positive for vimentin only), and one cannot be classified (negative for all stains). On the other hand, the variation in staining characteristics does not necessarily exclude these tumors from the category of malignant fibrous histiocytomas because there is great variability in staining patterns in human MFH. Using the small number of tumors in this study, the significance of the lack of staining by alpha,-antitrypsin is not certain. Some MFH of human beings do stain with alpha,-antitrypsin,28 but other reports demonstrate either no staining with histiocytic markers2' or low specificity of alpha,-antitrypsin as a histiocytic marker.30 In our laboratory alpha,-antitrypsin does stain feline inflammatory macrophages and giant cells; therefore, the antibody does work with feline tissue. The lack of staining of the feline MFH may be due to the reported low specificity of the marker or to the small sample size used in this study.
Morphologic assessment remains the most reliable diagnostic tool for diagnosis of feline malignant fibrous histiocytoma. Variable morphologic patterns, demonstrating histiocytic and fibroblastic characteristics, and variable amounts of other characteristics such as giant cells, bizarre mitotic figures, and storiform patterns may also be present. The use of the immunohistochemical stains discussed in this paper may be most useful in distinguishing malignant fibrous histiocytomas from other tumors with similar histologic features by virtue of positive staining with a variety of antibodies to antigens not generally associated with spindle cell tumors. 
